1. Tiotropium Respimat® in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials 
Felix Ratjen, Paul Koker, David E. Geller, Berengere Langellier-Cocteaux, Florence Le Maulf, Sabine Kattenbeck, Petra Moroni-Zentgraf, J. Stuart Elborn 
Journal of Cystic Fibrosis 
Volume 14, Issue 5, Pages (September 2015)
DOI: /j.jcf
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Adjusted mean FEV1 AUC0–4h (percent-predicted±SE) change from baseline by weeks (FAS). A. phase 3 trial; B. pooled phase 2 and 3 trials. AUC0–4h, area under the curve from 0 to 4h; FAS: full analysis set; FEV1: forced expiratory volume in 1s; SE: standard error.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions